GLAVINE PAUL (Chief Growth Officer) received a stock award from HELUS PHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/2/2026ACC: 0000912282-26-001332
Officer· Chief Growth Officer
Since Aug 2026
+248K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
248K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+248K
Price / share
—
Trade value
—
% of position
5.5%
9/30/2026
4.50M→4.75M
Total
Net shares
+248K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/30/2026 | A · Award | +248K | — | — | 5.5% | 4.50M | 4.75M |
| Total | +248K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported